Tenofovir Disoproxil Fumarate Tablets IP 300Mg - TENQUOR 300 Tablets

TENQUOR 300 Tablets – First-Line Choice for Long-Term Viral Suppression.

TENQUOR 300 Tablets – Tenofovir Disoproxil Fumarate Tablets IP 300Mg is a nucleotide reverse transcriptase inhibitor (NtRTI) widely prescribed in the management of HIV-1 infection and chronic Hepatitis B virus (HBV) infection. It works by blocking viral replication, thereby lowering viral load, slowing disease progression, and supporting immune system recovery. As a proven first-line therapy, Tenofovir Disoproxil Fumarate offers reliable antiviral efficacy and long-term clinical benefits in both HIV and HBV patients.

Key Benefits of Tenofovir Disoproxil Fumarate – TENQUOR 300 Tablets
✅ Dual Antiviral Power – Effective against both HIV-1 and chronic HBV infections.
✅ Well-Established Efficacy – Clinically proven to reduce viral replication and delay disease progression.
✅ First-Line Therapy – Recommended worldwide in ART and HBV treatment guidelines.
✅ Convenient Once-Daily Dose – Improves patient adherence and treatment outcomes.

Recommended by Specialists
👨‍⚕️ Hepatologists & Gastroenterologists – For effective control of chronic HBV infection and prevention of liver complications.
👨‍⚕️ HIV Specialists – As a key backbone agent in antiretroviral therapy (ART) regimens.
👨‍⚕️ General Physicians – For long-term management of HIV and HBV in routine care.

Indications
✅ HIV-1 Infection (in combination with other antiretrovirals)
✅ Chronic Hepatitis B Virus (HBV) Infection
✅ Long-term Antiviral Therapy for Immunocompromised Patients
✅ Core Component of ART for Adults and Adolescents